BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types

  August 8, 2025

   · 

  4 min read
• Press Releases

  Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care

  August 8, 2025

   · 

  2 min read
• Press Releases

  Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy

  August 8, 2025

   · 

  4 min read
• Press Releases

  Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment

  August 8, 2025

   · 

  3 min read
• Press Releases

  Sebela Pharmaceuticals® Announces Successful Completion of Phase 3 TRIUMpH Program of Tegoprazan in GERD with Positive 24-Week Maintenance Phase Results

  August 8, 2025

   · 

  9 min read
• Press Releases

  Quoin Pharmaceuticals Announces Second Quarter 2025 Financial Results and Corporate Update

  August 8, 2025

   · 

  10 min read
• Press Releases

  Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel PDE4 Inhibitor, PALI-2108

  August 8, 2025

   · 

  7 min read
• Press Releases

  Merit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology

  August 8, 2025

   · 

  5 min read
• Press Releases

  Disc Medicine Reports Second Quarter 2025 Financial Results and Provides Business Update

  August 8, 2025

   · 

  10 min read
• Press Releases

  SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification

  August 8, 2025

   · 

  4 min read